高スループットプロセス開発の世界市場予測（～2021）：モノクローナル抗体、組換えインスリン...市場調査レポートについてご紹介

1 Introduction (Page No. – 13)
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Covered
1.2.2 Years Considered for the Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders

2 Research Methodology (Page No. – 16)
2.1 Research Approach
2.1.1 Key Data From Secondary Sources
2.1.2 Key Data From Primary Sources
2.1.2.1 Key Industry Insights
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study

3 Executive Summary (Page No. – 24)

4 Premium Insights (Page No. – 29)
4.1 High Throughput Process Development Market Snapshot: 2016 vs 2021
4.2 High Throughput Process Development Market, By Product and Region
4.3 High Throughput Process Development Market, By Molecule Type, 2016 vs 2021 (USD Billion)
4.4 High Throughput Process Development Market, By Process, 2016 vs 2021 (USD Billion)
4.5 High Throughput Process Development Market, By End User, 2016 vs 2021 (USD Billion)
4.6 High Throughput Process Development Market, By Region

5 Market Overview (Page No. – 33)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing R&D Spending
5.2.1.2 Technological Advancements in Process Development
5.2.1.3 Growth in the Biopharmaceutical Industry
5.2.1.4 Growing Pressure to Lower the Cost of Manufacturing
5.2.2 Restraints
5.2.2.1 High Cost of Advanced High Throughput Process Development Technologies and Lack of Adequate Infrastructural Facilities
5.2.3 Current Trends
5.2.3.1 Outsourcing to Contract Manufacturing Organizations
5.2.3.2 Adoption of Quality By Design(QBD) Principles

6 High Throughput Process Development Market, By Product & Service (Page No. – 40)
6.1 Introduction
6.2 Consumables & Reagents
6.3 Instruments
6.4 Software & Services

7 High Throughput Process Development Market, By End User (Page No. – 47)
7.1 Introduction
7.2 Biopharmaceutical Manufacturers
7.3 Contract Manufacturing Organizations

8 High Throughput Process Development Market, By Molecule Type (Page No. – 53)
8.1 Introduction
8.2 Monoclonal Antibodies
8.3 Vaccines
8.4 Recombinant Insulin
8.5 Human Growth Hormones
8.6 Other Molecules

9 High Throughput Process Development Market, By Process (Page No. – 64)
9.1 Introduction
9.2 Downstream Processing
9.3 Upstream Processing

10 High Throughput Process Development Market, By Region (Page No. – 71)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 U.K.
10.3.3 Rest of Europe (RoE)
10.4 Asia-Pacific
10.5 Rest of the World (RoW)

11 Competitive Landscape (Page No. – 97)
11.1 Overview
11.2 Comparative Assessment of Key Market Players
11.3 Compettitive Situation and Trends
11.3.1 Product Launches
11.3.2 Agreements and Partnerships
11.3.3 Acquisitions
11.3.4 Expansions
11.3.5 Other Strategies

12 Company Profiles (Page No. – 105)
(Overview, Products and Services, Financials, Strategy & Development)*
12.1 Introduction
12.2 Danaher Corporation
12.3 GE Healthcare
12.4 Thermo Fisher Scientific Inc.
12.5 Merck Millipore
12.6 Agilent Technologies, Inc.
12.7 Bio-Rad Laboratories, Inc.
12.8 Eppendorf AG
12.9 Perkinelmer, Inc.
12.10 Sartorius Stedim Biotech
12.11 Tecan Group Ltd.

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. – 136)
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Other Developments
13.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.5 Introducing RT: Real-Time Market Intelligence
13.6 Available Customizations
13.7 Related Reports
13.8 Author Details